From: SBRT for centrally localized NSCLC – What is too central?
Level of acceptance | High (>85%) | Intermediate | Low (<50%) |
---|---|---|---|
Case Nr. | 5, 6, 9 | 1, 2, 3, 7, 8 | 4 |
Most critical organ at risk | Main bronchus, esophagus, aorta | Main bronchus, upper lobe bronchus, aorta | Main bronchus |
Maximal tumor diameter (range/median) | 2.1–3.7 cm/3.5 cm | 1.9–5.7 cm/4.7 cm | 7.6 cm |
Minimal distance to carina (range/median) | 7.5–8.3 cm/7.8 cm | 2.5–6.5 cm/3.8 cm | 0 cm |
Minimal distance to main bronchus (range/median) | 1.9–4.6 cm/2.2 cm | 0–0.5 cm/0 cm | 0 cm |
Alternative treatment | RT 70 Gy/35 fr. | RCT: 66 Gy/33 fr. | RT: 30 Gy/10 fr. or RCT: 66 Gy/33 fr. |
Most frequently stereotactic fractionation | 60 Gy/8 fr. | 60 Gy/8 fr. | 40 Gy/8 fr. |
Second most frequently stereotactic fractionation | 37,5–50 Gy/3 fr. | 35–40 Gy/5 fr. 48 Gy/8 fr. | - |